Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)
Status:
Completed
Trial end date:
2020-02-13
Target enrollment:
Participant gender:
Summary
This is a study to examine the effect of combining chronic oral azithromycin with inhaled
tobramycin in adolescent and adult subjects with cystic fibrosis who are chronically infected
with P. aeruginosa.
Phase:
Phase 4
Details
Lead Sponsor:
Seattle Children's Hospital
Collaborators:
CF Therapeutics Development Network Coordinating Center Cystic Fibrosis Foundation Cystic Fibrosis Foundation Therapeutics National Heart, Lung, and Blood Institute (NHLBI)